Form D · Other Technology
NeuroBionics Inc.
Somerville, MA · CIK 0002100415
Offering snapshot reported Dec 10, 2025 · SEC filing
- Reported sold
- $4.25M Offering amount: $4.25M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 25, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 10, 2025 | Initial | $4,249,990 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-566402
Source: Form D, filed Dec 10, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Polina Anikeeva | Director |
| Marc Joseph Antonini | Director, Executive |
| Nicolette Driscoll | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
444 Somerville Ave.
Somerville, MA, 02143
Somerville, MA, 02143